Johnson & Johnson wins appeal to overturn $151 million hip implant verdict

(Reuters) - Johnson & Johnson on Wednesday secured a favorable U.S. appellate court ruling, overturning a verdict that had awarded $151 million to five people who blamed injuries they suffered on the company's Pinnacle hip implant devices.

Novartis' digital drive continues with eye-disease app

ZURICH (Reuters) - Novartis's foray into digital technology intensified on Wednesday as the Swiss drugmaker launched a mobile-phone based app to help collect data from people participating in eye disease studies.

Mom's depression tied to kids' emotional, intellectual development

(Reuters Health) - A mother’s depression is linked with her children's development from infancy through adolescence, according to a new study.

Fatigue a major risk in ridesharing industry

(Reuters Health) - Fatigue and sleepiness are inherent safety risks in the ridesharing industry today, the American Academy of Sleep Medicine warns.

FDA says reviewing Acadia's Parkinson's medication, shares fall

WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.

Wounded soldier gets world's first penis transplant in U.S. operation

(Reuters) - A soldier wounded by an improvised explosive device in Afghanistan has received the world's first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday.

U.S. cannot cut teen pregnancy prevention grants : federal judge

(Reuters) - A federal judge has blocked U.S. President Donald Trump's administration from terminating grant funding for teen pregnancy prevention programs run by affiliates of Planned Parenthood, saying the decision was arbitrary.

U.S. court upholds dismissal of $200 million Merck verdict against Gilead

(Reuters) - A U.S. appeals court on Wednesday affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a $200 million infringement verdict it won against rival Gilead Sciences Inc.

Court rules gravely ill UK child cannot travel to Vatican hospital

LIVERPOOL, England (Reuters) - A British court rejected an appeal on Wednesday from parents of a gravely ill 23-month-old boy to take their son to Italy for treatment, a case that has drawn international attention, including from Pope Francis.

Income, education tied to physical function in old age

(Reuters Health) - People with lower socioeconomic status may have fewer years of good physical functioning in old age than their more affluent, educated counterparts, a recent study suggests.

Related Videos

UK firm turns discarded gum into shoes, coffee cups, and combs

Plastic-eating enzyme holds promise in fighting pollution - scientists

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here